SEIZINGER BERND R. enters ONCOLYTICS BIOTECH INC with 366.99K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 366.99K | Direct |
| Total | 366.99K | 366.99K direct |
Stock Option
DirectUnderlying shares
30K
Shares owned
N/A
Exercise price
1.14
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
30K
Shares owned
N/A
Exercise price
3.40
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
30K
Shares owned
N/A
Exercise price
1.13
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
120K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
30K
Shares owned
N/A
Exercise price
2.76
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
30K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Underlying
270K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Shares | 1.14 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 3.40 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 1.13 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 1.08 | — | — | 120K | N/A |
| Stock Option Direct | Common Shares | 2.76 | — | — | 30K | N/A |
| Stock Option Direct | Common Shares | 1.08 | — | — | 30K | N/A |
| Total | 270K | 0.00 | ||||